BRM Group
BRM Group, established in 1988, is a Tel Aviv-based private equity firm specializing in early-stage investments. It focuses on sectors such as life sciences, healthcare, consumer goods, and technology, with a particular interest in fintech, consumer, medtech, and enterprise companies. The firm aims to build diverse investment portfolios, primarily in the digital and internet sectors.
Top Stages
1 past transactions
Innoventric
Series B in 2024
Innoventric is a medical device company based in Ness-Ziona, Israel, focused on developing innovative percutaneous solutions for Tricuspid Regurgitation and right heart disease. Founded in 2017, the company has made significant advancements with its proprietary Trillium™ technology, designed to treat Tricuspid Valve Regurgitation. Innoventric's device features a functional tricuspid valve replacement that employs cross-caval anchoring and a multi-valve design, aimed at enhancing blood flow regulation. The company has conducted over ten implantations of the Trillium™ technology as part of its first human clinical trial in Europe. Additionally, Innoventric maintains a comprehensive patent portfolio for the Trillium™ and related technologies, positioning itself as a key player in the structural heart medical device sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.